Behind-the-paper: Whole-genome Sequencing Identifies Responders to Pembrolizumab in Relapse/Refractory Natural-killer/T Cell Lymphoma Contributor Leukemia Behind the paper Behind-the-paper: Whole-genome Sequencing Identifies Responders to Pembrolizumab in Relapse/Refractory Natural-killer/T Cell Lymphoma +3 Jing Quan Lim and 3 others Aug 05, 2020
